Health Topics — Women's Health
When Your Body Feels Like It's Working Against You
For the woman whose hormonal experience hasn't been adequately explained or addressed — what the research on the endocannabinoid system and women's health has begun to examine.

Women's bodies operate on a more complex hormonal rhythm than most medicine was designed to account for. The menstrual cycle, the monthly fluctuations in estrogen and progesterone, the transition into peri-menopause — these are not minor variations. They are fundamental features of female physiology that shape everything from mood and sleep to pain sensitivity and stress response. And they are systematically underrepresented in the research that most health advice draws from.What has emerged more recently is a picture of a system in the body — the endocannabinoid system — that is deeply intertwined with the hormonal systems that govern these experiences. Understanding that relationship doesn't resolve every question. But it offers something most advice doesn't: a biological explanation for why your body responds the way it does, and why it might respond differently at different points in your cycle or your life.
Why your body responds differently at different times
Estrogen and the endocannabinoid system are not separate systems. They interact directly. Estrogen influences the production and breakdown of anandamide — one of the body's own endocannabinoids, sometimes called the "bliss molecule" for the role it plays in mood, pain perception, and stress regulation. When estrogen is higher, anandamide tends to be more available. When estrogen drops — at the end of a cycle, or more dramatically during peri-menopause — that availability falls with it.In plain terms: the pain that feels worse before your period, the mood that darkens in the days before bleeding begins, the anxiety that spikes at predictable times — these are not character flaws or failures of resilience. They track estrogen fluctuation. And estrogen fluctuation changes the biology of how well your body can regulate pain, stress, and mood in that moment. The endocannabinoid system is one of the mechanisms through which that regulation happens.Cortisol adds another layer. Chronic stress suppresses estrogen production and disrupts the hormonal rhythms that healthy cycles depend on. At the same time, high cortisol reduces CB1 receptor sensitivity — meaning the endocannabinoid system's ability to do its regulatory work is diminished precisely when stress is high and the body needs it most. For women carrying sustained stress load, this creates a compounding pattern: stress suppresses hormones, suppressed hormones reduce endocannabinoid tone, reduced endocannabinoid tone makes stress harder to resolve.What the research on CBG and CBD has examined
CBD interacts with the enzyme (FAAH) that breaks down anandamide. By slowing that breakdown, CBD may support higher anandamide availability — which is relevant in the low-estrogen phases of the cycle when anandamide tends to be depleted. This is preclinical research: it tells us about a biological mechanism, not a clinical outcome. But the mechanism is directly relevant to the experience of hormonal fluctuation.CBG has been studied in the context of stress regulation — specifically, the first controlled human trial of CBG found measurably reduced anxiety and stress compared to placebo in healthy adults. Because stress is one of the primary disruptors of hormonal health in women, this research is relevant here even though it was not conducted in a women's health population specifically. A preparation that supports the body's stress response may, through that mechanism, support the hormonal stability that stress tends to disrupt.Research has also examined CB1 receptor expression throughout the reproductive system — in uterine tissue, in ovarian tissue, along the hormonal signaling pathways that govern the cycle. The endocannabinoid system is present throughout these structures. The implications of that presence are still being understood, but the architecture is documented.On what we can and cannot sayThe research described here is mechanistic and preclinical — it documents biological relationships, not clinical outcomes. No human trial has tested CBG or CBD specifically for hormonal regulation, menstrual pain management, or peri-menopausal symptoms in a controlled way that would support a treatment claim.The mechanisms are real. The clinical evidence is still developing. We present the research in that proportion — not understated, not overstated.